BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 86624)

  • 1. [Clinical experience with NK 631 (pepleomycin) for malignant tumors of skin (author's transl)].
    Seki T; Shimada S; Ohara K
    Jpn J Antibiot; 1979 Feb; 32(2):278-81. PubMed ID: 86624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topical chemotherapy for carcinoma of the skin (author's transl)].
    Miki Y; Kawatsu T; Matsuda H; Yamada T; Kahata A
    Jpn J Antibiot; 1975 Feb; 28(1):37-43. PubMed ID: 47924
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with NK 631 in malignant tumors of skin (author's transl)].
    Nobe O; Kubo H; Yoshii K; Tashiro M
    Jpn J Antibiot; 1979 Mar; 32(3):463-9. PubMed ID: 86628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cutaneous arsenism treated with aromatic retinoid.
    Thianprasit M
    J Med Assoc Thai; 1984 Feb; 67(2):93-100. PubMed ID: 6736831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Retinoids in the treatment of epithelial skin tumors].
    Berretti B; Grupper C
    Ther Umsch; 1986 Sep; 43(9):703-6. PubMed ID: 3535155
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of morbus Bowen with 5-fluoro-uracil ointment (author's transl)].
    Krause H; Grussendorf EI
    Derm Beruf Umwelt; 1979; 27(6):176-8. PubMed ID: 550993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Photodynamic therapy can be used for treatment of superficial skin tumors. Cosmetic results especially advantageous].
    Tarstedt M; Wennberg AM
    Lakartidningen; 2007 Feb 7-13; 104(6):426-9. PubMed ID: 17373290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical and histopathological appraisal of disappearance of basal cell epitheliomas and Bowen's disease under the influence of colchamine ointment].
    Rubisz-Brzezińska J; Smigla A
    Przegl Dermatol; 1976; 63(6):865-74. PubMed ID: 188077
    [No Abstract]   [Full Text] [Related]  

  • 10. Making light work of Bowen's disease.
    Lancet; 1989 Jan; 1(8628):24-5. PubMed ID: 2563007
    [No Abstract]   [Full Text] [Related]  

  • 11. Usage and patient experience of 5% fluorouracil cream.
    Gibbs S; Davis T
    Clin Exp Dermatol; 2015 Jan; 40(1):88. PubMed ID: 25266259
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with pepleomycin (NK 631) (author's transl)].
    Hashimoto K; Shioda S; Amagasa T; Shimizu M; Sato O; Ito H; Fujibayashi T; Soda T
    Jpn J Antibiot; 1979 Mar; 32(3):451-62. PubMed ID: 86627
    [No Abstract]   [Full Text] [Related]  

  • 13. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
    Gayl Schweitzer V
    Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etretinate in bowenoid papulosis.
    De Mari F; Rampen FH; van Everdingen JJ
    Lancet; 1981 Oct; 2(8252):936-7. PubMed ID: 6117716
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of epitheliomas].
    Revenga Arranz F
    Rev Clin Esp; 1997 Dec; 197(12):841-6. PubMed ID: 9477677
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with pepleomycin (NK 631) (author's transl)].
    Kusakari J; Sato Y; Saijo S; Tomioka S; Kawamoto K
    Jpn J Antibiot; 1978 Nov; 31(11):659-63. PubMed ID: 83402
    [No Abstract]   [Full Text] [Related]  

  • 17. Photodynamic therapy for the treatment of skin disease.
    Kendall CA; Morton CA
    Technol Cancer Res Treat; 2003 Aug; 2(4):283-8. PubMed ID: 12892510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic Therapy: Influence of Clinical and Procedure Variables on Treatment Response in Basal Cell Carcinoma and Bowen Disease.
    Gracia-Cazaña T; Mascaraque M; Salazar N; Vera-Álvarez J; Frías MP; González S; Juarranz Á; Gilaberte Y
    Acta Derm Venereol; 2018 Jan; 98(1):116-118. PubMed ID: 28761963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etretinate and 5-fluorouracil in intra-anal Bowen's disease].
    Schmidt KU; Wiskemann A; Mensing H
    Hautarzt; 1986 May; 37(5):278-80. PubMed ID: 3733447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional bleomycin.
    Dyall-Smith D
    Australas J Dermatol; 1998 May; 39(2):123-4. PubMed ID: 9611387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.